ClassID:

116848

C12Y304/21047 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Serine endopeptidases (3.4.21) Alternative-complement-pathway C3/C5 convertase (3.4.21.47), i.e. properdin factor B

Recent Application in this class:
#1
20260022382
2026-01-22

Compositions and Methods for Modulating Complement Factor B Expression

#2
20240376477
2024-11-14

COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#3
20240247268
2024-07-25

Modulators of Complement Factor B

#4
20230357776
2023-11-09

COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION

#5
20230057718
2023-02-23

Compositions and methods for modulating complement factor B expression

#6
20220276261
2022-09-01

C3/C5 CONVERTASE ASSAYS

#7
20220243209
2022-08-04

Modulators of Complement Factor B

#8
20220213486
2022-07-07

COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#9
20200339998
2020-10-29

COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#10
20200325464
2020-10-15

Complement factor B analogs and their uses

#11
20200263183
2020-08-20

Complement component iRNA compositions and methods of use thereof

#12
20200149047
2020-05-14

MODULATORS OF COMPLEMENT FACTOR B

#13
20200048638
2020-02-13

COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION

#14
20190338268
2019-11-07

Complement factor B analogs and their uses

#15
20190048351
2019-02-14

MODULATORS OF COMPLEMENT FACTOR B

#16
20180320180
2018-11-08

AGE-RELATED MACULAR DEGENERATION TREATMENT

#17
20170159055
2017-06-08

Compositions and methods for modulating complement factor B expression

#18
20170037391
2017-02-09

Complement factor B analogs and their uses

#19
20160298124
2016-10-13

Complement component iRNA compositions and methods of use thereof

#20
20160145611
2016-05-26

Age-related macular degeneration treatment

#21
20160082091
2016-03-24

Complement factor B analogs and their uses

#22
20150175994
2015-06-25

Heat-inactivated complement factor B compositions and methods

#23
20120264813
2012-10-18

SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

#24
20120220496
2012-08-30

siRNA targeting catenin, Beat-1 (CTNNB1)

#25
20120136144
2012-05-31

SiRNA targeting catenin, beta-1 (CTNNB1)

#26
20110269951
2011-11-03

siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

#27
20110105363
2011-05-05

siRNA targeting TNFa

#28
20100248990
2010-09-30

siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)

#29
20100145039
2010-06-10

siRNA targeting nucleoporin 62kDa (Nup62)

#30
20100016573
2010-01-21

SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

#31
20090306356
2009-12-10

siRNA targeting TNFα

#32
20090275640
2009-11-05

siRNA targeting inner centromere protein antigens (INCENP)

#33
20090118489
2009-05-07

siRNA targeting nucleoporin 62kDa (Nup62)

#34
20090069265
2009-03-12

siRNA targeting inner centromere protein antigens (INCENP)

#35
20080227967
2008-09-18

siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)

#36
20080177051
2008-07-24

siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)